Skip to main content

LMR Partners LLP

Position in GH — Guardant Health, Inc.

CIK 1578621 LONDON, X0

Position in GH

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,411,582
+$695,630 QoQ
Shares Held
16,074
-4.3% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#248
of 594 holders
Holding Since
Mar 2021
11 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in GH Over Time

Shares Held

Position Value (USD)

Derivatives in GH

reported options exposure · as of Dec 31, 2025
CallValue
$2,870,134
CallShares
28,100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

LMR Partners LLP holds $133,235,479 across 9 Diagnostics & Research names. GH ranks #5 (1.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 GH
Guardant Health, Inc.
This page
16,074 $2,411,582

All Filings in GH

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,411,582 16,074
2025-12-31 $1,715,952 16,800
2025-12-31 $2,870,134 28,100
2025-09-30 $424,864 6,800
2025-09-30 $1,755,688 28,100
2025-03-31 $490,922 11,524
2024-09-30 $229,400 10,000
2022-09-30 $2,046,132 38,011
2022-06-30 $6,480,378 160,644
2022-03-31 $1,519,678 22,942
2021-12-31 $14,757,650 147,547
2021-09-30 $6,090,612 48,721
2021-03-31 $5,366,105 35,153